查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2132186

全球醫藥冷鏈包裝市場規模、佔有率、成長及產業分析：按材料、包裝類型、產品類型、最終用途和區域分類，預測至2034年

Global Pharmaceutical Cold Chain Packaging Market Size, Share, Growth, and Industry Analysis, By Material Type, By Packaging Type, By Product Type, By End-use, and Regional Forecast to 2034
出版日期: | 出版商: Prismane Consulting | 英文 149 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球醫藥冷鏈包裝市場

全球醫藥冷鏈包裝市場預計在2025年達到207億美元，到2034年將達到468億美元，2026年至2034年的複合年成長率（CAGR）為9.5%。全球醫藥冷鏈包裝市場正經歷強勁成長，這主要得益於醫藥和醫療保健供應鏈中對疫苗、生物製藥、特藥、臨床試驗材料和其他溫度敏感產品可靠的溫控包裝需求不斷成長。冷鏈包裝在儲存和運輸過程中發揮著至關重要的作用，它能夠維持必要的溫度條件，同時保護產品免受溫度偏差、物理損傷、潮濕和污染的影響。預計到2034年，藥品產量增加、生物製藥研發、全球藥品分銷以及特藥市場的擴張將進一步推動市場發展。

全球醫藥冷鏈包裝市場

全球醫藥冷鏈包裝市場正在蓬勃發展，涵蓋塑膠、玻璃、金屬及其他材料，包括主動式和被動式包裝解決方案。塑膠因其輕盈、耐用、隔熱和設計柔軟性等優點，佔據了重要的材料佔有率。被動式包裝無需外部電源即可維持指定溫度範圍，因此仍被廣泛採用；而主動式包裝系統則擴大用於需要精確且長期溫度控制的高價值商品。保溫包裝、凝膠包、冰袋和真空絕熱板（VIP）運輸箱是醫藥物流中的關鍵產品類型。

市場促進因素

市場的主要促進因素是溫度敏感型藥品（尤其是生物製藥、疫苗、細胞和基因療法以及特種藥品）的快速成長。全球藥品貿易的擴張、臨床試驗活動的活性化、醫療服務分散化以及對可靠的「最後一公里」配送需求的不斷成長，都進一步提高了對冷鏈包裝的要求。更嚴格的溫度控制標準、對減少產品損耗的日益重視以及對經過驗證的包裝系統的需求，都在進一步推動市場成長。

市場限制因素

該市場面臨許多挑戰，例如先進包裝、溫控材料、專用容器和驗證流程的高成本。複雜的國際物流、各地區不同的溫度要求以及對認證包裝系統的需求都會導致營運成本增加。此外，一次性隔熱材料和冷媒的處置和回收也會引發環境問題。而且，由於延誤、操作不當、極端天氣或包裝選擇不當造成的溫度偏差，都可能造成重大的產品損失。

目錄

第1章：引言

第2章 市場概況

第3章：經濟與能源展望

  • 國內生產毛額和人口統計數據
  • 貨幣/財政政策

第4章 藥品冷鏈包裝簡介：市場概覽

  • 產品概述
  • 等級和特性
  • 原料
  • 製造過程
  • 環境問題
  • 價值鏈
  • 目的

第5章 市場動態與產業趨勢

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
    • 任務

第6章：2018-2034年全球藥品冷鏈包裝需求分析

  • 戰略挑戰及新冠疫情的影響
  • 需求分析與預測，2018-2034年
    • 要求
    • 需求成長率（%）
    • 促進因素分析
    • 其他功能性成分
  • 全球醫藥冷鏈包裝市場：依材料類型分類
    • 塑膠
    • 玻璃
    • 金屬
    • 其他
  • 全球醫藥冷鏈包裝市場：依產品類型分類
    • 保溫運輸容器
    • 凝膠包和冰袋
    • 真空絕熱板和運輸箱
    • 其他
  • 全球醫藥冷鏈包裝市場：依包裝類型分類
    • 活性包裝
    • 被動式封裝
  • 全球醫藥冷鏈包裝市場：依最終用途產業分類
    • 製藥
    • 衛生保健
    • 研究機構和研究單位
    • 其他

第7章 需求分析與市場概覽：按地區和國家分類，2018-2034年

  • 戰略挑戰及新冠疫情的影響
  • 需求分析與預測，2018-2034年
  • 需求成長率（%）
  • 醫藥冷鏈包裝市場：依材料類型分類
  • 醫藥冷鏈包裝市場：依產品類型分類
  • 醫藥冷鏈包裝市場：依包裝類型分類
  • 醫藥冷鏈包裝市場：依最終用途分類
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 西歐
    • 德國
    • 法國
    • 義大利
    • 英國
    • 西班牙
    • 其他西歐國家
  • 中歐和東歐國家
    • 俄羅斯
    • 波蘭
    • 土耳其
    • 其他中歐和東歐國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中美洲和南美洲
    • 巴西
    • 阿根廷
    • 其他中南美洲
  • 中東
    • 沙烏地阿拉伯
    • UAE
    • 其他中東國家
  • 非洲
    • 南非
    • 其他中東和非洲國家

第8章：價格分析

第9章：關鍵策略挑戰與商業機會評估

  • 市場吸引力評估
  • 對未來和目標市場的研究

第10章 戰略建議與提案

第11章：公司分析與市佔率分析

  • 醫藥冷鏈包裝市場：製造商概況及公司分析
    • 基本資料
    • 總部、主要市場
    • 所有權結構
    • 公司財務狀況
    • 製造地
    • 全球整體銷售
    • 員工總數
    • 產品系列/服務/解決方案
    • 關鍵業務策略概述及Prisman Consulting所採用的策略
    • 近期趨勢
    • 目標公司
      • Sonoco ThermoSafe
      • Cold Chain Technologies
      • CSafe Global
      • Peli BioThermal
      • Intelsius
      • Cryopak
      • va-Q-tec
      • Softbox Systems
      • Sofrigam
      • Emball'Iso
      • Topa Thermal
      • Sealed Air（SEE）
      • 其他製造商

第12章附錄

簡介目錄

Global Pharmaceutical Cold Chain Packaging Market

The global pharmaceutical cold chain packaging market was valued at USD 20.7 billion in 2025 and is projected to reach USD 46.8 billion by 2034, expanding at a CAGR of 9.5% during 2026-2034. The global Pharmaceutical Cold Chain Packaging Market is witnessing strong growth as pharmaceutical and healthcare supply chains increasingly require reliable temperature-controlled packaging for vaccines, biologics, specialty drugs, clinical trial materials, and other temperature-sensitive products. Cold chain packaging helps maintain required temperature conditions during storage and transportation while protecting products from temperature excursions, physical damage, moisture, and contamination. Increasing pharmaceutical production, biologics development, global drug distribution, and expansion of specialty medicines are expected to support market development through 2034.

Global Pharmaceutical Cold Chain Packaging Market

The global Pharmaceutical Cold Chain Packaging Market is expanding across plastic, glass, metal, and other materials and includes active and passive packaging solutions. Plastic represents a significant material segment because of its lightweight characteristics, durability, insulation compatibility, and design flexibility. Passive packaging remains widely adopted because it can maintain required temperature ranges without an external power source, while active systems are increasingly used for high-value shipments requiring precise and extended temperature control. Insulated shippers, gel packs & ice packs, and vacuum insulated panel (VIP) shippers represent important product categories across pharmaceutical logistics.

Demand by Material Type

Plastic is expected to account for a significant share of demand due to its lightweight construction, durability, moisture resistance, and compatibility with insulated packaging systems. Glass remains important because many pharmaceutical products, biologics, vaccines, and injectable medicines are stored in glass vials and containers that require secondary temperature-controlled protection. Metal is used in specialized cold chain containers and durable transport systems where strength and thermal performance are important. Other materials include expanded insulation materials, specialty composites, fiber-based solutions, and advanced thermal barrier materials.

Demand by Packaging Type

Passive packaging is expected to represent a major share of the market because of its cost-effectiveness, portability, ease of deployment, and suitability for short- and medium-duration pharmaceutical shipments. These systems commonly use insulated containers with gel packs, ice packs, phase-change materials, or vacuum insulation. Active packaging is increasingly adopted for high-value pharmaceuticals and long-distance shipments requiring tighter temperature control, particularly for biologics and specialty medicines. Continued development of advanced thermal management systems is improving temperature stability and shipment reliability.

Demand by Product Type

Insulated shippers are expected to account for a significant share of demand due to their widespread use for pharmaceutical and healthcare shipments requiring controlled temperature conditions. Gel packs & ice packs remain important because they provide practical and cost-effective temperature control for numerous cold chain applications. Vacuum insulated panel (VIP) shippers are gaining adoption because of their superior insulation performance and ability to provide extended temperature protection while maintaining relatively compact package dimensions. Other products include phase-change material systems, temperature-controlled containers, thermal blankets, and specialized shipping boxes.

Demand by End-Use

Pharmaceutical applications represent the dominant end-use segment due to increasing transportation of vaccines, biologics, injectable drugs, specialty medicines, and temperature-sensitive formulations. Healthcare applications are supported by the distribution of diagnostic products, medical supplies, blood products, and other temperature-sensitive healthcare materials. Laboratories & research organizations generate demand for cold chain packaging for clinical trials, biological samples, research reagents, and experimental materials. Other applications include biotechnology, contract research organizations, specialty pharmacies, and healthcare logistics providers.

Market Driver

The primary market driver is the rapid expansion of temperature-sensitive pharmaceutical products, particularly biologics, vaccines, cell and gene therapies, and specialty medicines. Increasing global pharmaceutical trade, clinical trial activity, decentralized healthcare delivery, and demand for reliable last-mile distribution are creating greater requirements for cold chain packaging. Stricter temperature-control standards, increasing focus on reducing product losses, and the need for validated packaging systems are further supporting market growth.

Market Restraint

The market faces challenges from the high cost of advanced insulated packaging, temperature-control materials, specialized containers, and validation processes. Complex international logistics, varying temperature requirements, and the need for qualified packaging systems can increase operating expenses. Disposal and recycling of single-use insulation materials and refrigerants can also create environmental concerns. Furthermore, temperature excursions caused by delays, improper handling, extreme weather, or inadequate packaging selection can result in significant product losses.

Demand by Region

North America is expected to remain a significant market due to its advanced pharmaceutical industry, extensive healthcare infrastructure, strong biologics production, and established cold chain logistics network. Europe is supported by pharmaceutical manufacturing, stringent quality requirements, increasing biologics demand, and investments in temperature-controlled supply chains. Asia Pacific is expected to witness strong growth due to expanding pharmaceutical manufacturing, increasing healthcare expenditure, vaccine distribution, and growing clinical research activity across China, India, Japan, and Southeast Asia. Latin America is developing through improvements in pharmaceutical distribution and healthcare infrastructure, while the Middle East & Africa market is supported by increasing healthcare investments and expansion of temperature-sensitive pharmaceutical distribution.

Key Manufacturers

Sonoco ThermoSafe, Cold Chain Technologies, Pelican BioThermal, va-Q-tec, Softbox Systems, Cryopak, Inmark, CSafe, Envirotainer, SkyCell, DGP Intelsius, Sealed Air, FedEx Custom Critical, DHL, World Courier, American Aerogel, EcoCoolBox, Tempack, Insulated Products Corporation, and Avantor.

Table of Contents

1. Introduction

  • 1.1. Scope
  • 1.2. Market Coverage
    • 1.2.1. Material Type
    • 1.2.2. Product Type
    • 1.2.3. Packaging Type
    • 1.2.4. End-use
    • 1.2.5. Regions
    • 1.2.6. Countries
  • 1.3. Years Considered
    • 1.3.1. Historical - 2018 - 2024
    • 1.3.2. Base - 2025
    • 1.3.3. Forecast Period - 2026 - 2034
  • 1.4. Research Methodology
    • 1.4.1. Approach
    • 1.4.2. Research Methodology
    • 1.4.3. Prismane Consulting Market Models
    • 1.4.4. Assumptions & Limitations
    • 1.4.5. Abbreviations & Definitions
    • 1.4.6. Conversion Factors
    • 1.4.7. Data Sources

2. Market Synopsis

  • 2.1. Market Evolution
  • 2.2. Demand Overview
  • 2.3. Industry Structure
  • 2.4. Strategic Issues
  • 2.5. End-use Trends
  • 2.6. Growth Forecast

3. Economic & Energy Outlook

  • 3.1. GDP and Demographics
  • 3.2. Monetary & Fiscal Policies

4. Introduction to Pharmaceuticals Cold Chain Packaging and Market Overview

  • 4.1. Product Description
  • 4.2. Grades & Properties
  • 4.3. Raw Material
  • 4.4. Manufacturing Process
  • 4.5. Environmental Issues
  • 4.6. Value Chain
  • 4.7. Applications

5. Market Dynamics and Industry Trends

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunities
    • 5.1.4. Challenges

6. Global Pharmaceuticals Cold Chain Packaging Demand Analysis, By Material Type, By Product Type, By Packaging Type, and By End-use (Value) (2018-2034)

  • 6.1. Strategic Issues and COVID-19 Impact
  • 6.2. Demand Analysis and Forecast (2018 - 2034)
    • 6.2.1. Demand
    • 6.2.2. Demand Growth Rate (%)
    • 6.2.3. Driving Force Analysis
    • 6.2.4. Other Functional Ingredients
  • 6.3. Global Pharmaceuticals Cold Chain Packaging Market, By Material Type
    • 6.3.1. Plastic
    • 6.3.2. Glass
    • 6.3.3. Metal
    • 6.3.4. Others
  • 6.4. Global Pharmaceuticals Cold Chain Packaging Market, By Product Type
    • 6.4.1. Insulated Shippers
    • 6.4.2. Gel Packs and Ice Packs
    • 6.4.3. Vacuum Insulated Panels Shipper
    • 6.4.4. Others
  • 6.5. Global Pharmaceuticals Cold Chain Packaging Market, By Packaging Type
    • 6.5.1. Active Packaging
    • 6.5.2. Passive Packaging
  • 6.6. Global Pharmaceuticals Cold Chain Packaging Market, By End-use Industry
    • 6.6.1. Pharmaceutical
    • 6.6.2. Healthcare
    • 6.6.3. Laboratories & Research Organizations
    • 6.6.4. Others

7. Demand Analysis and Market Review, By Region, By Country (Value), (2018- 2034)

  • 7.1. Strategic Issues and COVID-19 Impact
  • 7.2. Demand Analysis and Forecast (2018-2034)
  • 7.3. Demand Growth Rate (%)
  • 7.4. Pharmaceuticals Cold Chain Packaging Market, By Material Type
  • 7.5. Pharmaceuticals Cold Chain Packaging Market, By Product Type
  • 7.6. Pharmaceuticals Cold Chain Packaging Market, By Packaging Type
  • 7.7. Pharmaceuticals Cold Chain Packaging Market, By End-Use
  • 7.8. North America
    • 7.8.1. USA
    • 7.8.2. Canada
    • 7.8.3. Mexico
  • 7.9. Western Europe
    • 7.9.1. Germany
    • 7.9.2. France
    • 7.9.3. Italy
    • 7.9.4. United Kingdom
    • 7.9.5. Spain
    • 7.9.6. Rest of Western Europe
  • 7.10. Central & Eastern Europe
    • 7.10.1. Russia
    • 7.10.2. Poland
    • 7.10.3. Turkey
    • 7.10.4. Rest of Central & Eastern Europe
  • 7.11. Asia-Pacific
    • 7.11.1. China
    • 7.11.2. Japan
    • 7.11.3. India
    • 7.11.4. South Korea
    • 7.11.5. ASEAN
    • 7.11.6. Rest of Asia-Pacific
  • 7.12. Central & South America
    • 7.12.1. Brazil
    • 7.12.2. Argentina
    • 7.12.3. Rest of Central & South America
  • 7.13. Middle East
    • 7.13.1. Saudi Arabia
    • 7.13.2. UAE
    • 7.13.3. Rest of Middle East
  • 7.14. Africa
    • 7.14.1. South Africa
    • 7.14.2. Rest of MEA

8. Pricing Analysis

9. Key Strategic Issues and Business Opportunity Assessment

  • 9.1. Market Attractiveness Assessment
  • 9.2. Prospective & Target Market Study

10. Strategic Recommendation & Suggestions

11. Company Analysis and Market Share Analysis

  • 11.1. Pharmaceuticals Cold Chain Packaging Manufacturers Profiles/ Company Analysis
    • 11.1.1. Basic Details
    • 11.1.2. Headquarter, Key Markets
    • 11.1.3. Ownership
    • 11.1.4. Company Financial
    • 11.1.5. Manufacturing Bases
    • 11.1.6. Global Turnover
    • 11.1.7. Total Employee
    • 11.1.8. Product Portfolio / Services / Solutions
    • 11.1.9. Key Business Strategies adopted and Prismane Consulting Overview
    • 11.1.10. Recent Developments
    • 11.1.11. Companies Covered
      • 11.1.11.1. Sonoco ThermoSafe
      • 11.1.11.2. Cold Chain Technologies
      • 11.1.11.3. CSafe Global
      • 11.1.11.4. Peli BioThermal
      • 11.1.11.5. Intelsius
      • 11.1.11.6. Cryopak
      • 11.1.11.7. va-Q-tec
      • 11.1.11.8. Softbox Systems
      • 11.1.11.9. Sofrigam
      • 11.1.11.10. Emball'Iso
      • 11.1.11.11. Topa Thermal
      • 11.1.11.12. Sealed Air (SEE)
      • 11.1.11.13. Other Manufacturers

12. Appendices

  • 12.1. Demand- Regions
  • 12.2. Demand- Countries